Intimacy a strong motivator for PrEP HIV prevention

August 19, 2014, Brown University
Many HIV-negative gay or bisexual men in steady relationships with other HIV-negative men don't always use condoms out of a desire for intimacy. That same desire, according to a new study, makes such men more inclined to use antiretroviral medications to prevent getting HIV, a practice known as PrEP. Credit: David Orenstein/Brown University

Men in steady same-sex relationships where both partners are HIV negative will often forgo condoms out of a desire to preserve intimacy, even if they also have sex outside the relationship. But the risk of HIV still lurks. In a new study of gay and bisexual men who reported at least one instance of condomless anal sex in the last 30 days, researchers found that the same desire for intimacy is also a strong predictor of whether men would be willing to take antiretroviral medications to prevent HIV, an emerging practice known as pre-exposure prophylaxis or PrEP.

Earlier this year the U.S. Public Health Service recommended that people at high risk of getting HIV use PrEP, including gay or who have condomless anal sex. But as the recommendation becomes clinical practice, many people are wondering whether men will make PrEP part of their daily lives and what will keep them motivated to adhere to it strictly, which is required if the medication is to have its protective effect.

The new study, published in the Annals of Behavioral Medicine, suggests that PrEP's appeal to many men who have sex with men (MSM) in romantic relationships with HIV-negative partners is the perception that it can allow them to remain intimate with their partners while still having some protection from HIV.

"In this sample of men who are in a relationship with a perceived HIV-negative man, we found that motivation was the strongest predictor [of adopting PrEP]," said Kristi Gamarel, a psychiatry and human behavior postdoctoral researcher in the Warren Alpert Medical School of Brown University. She was at the City University of New York with senior author and principal investigator for the NIH-funded project, Sarit Golub, when she performed the research. "Sex doesn't happen in a vacuum—interpersonal and relationship context really matter. Many HIV infections are occurring between people who are in a primary relationship."

The study is based on extensive interviews with 164 HIV-negative MSMs who were in steady same-sex relationships and who had condomless anal sex at least once in the prior 30 days. The researchers found in a multivariate statistical analysis that those who rated intimacy highly as a reason why they sometimes engage in condomless sex also were 54 percent more likely to say they would adopt PrEP if it were available for free (likely a hypothetical condition for many, but not necessarily all, recipients).

In basic analyses reported in the paper, there were several other factors in the study that also predicted a greater likelihood of adopting PrEP: , higher perception of HIV risk, sex (either protected or not) with partners outside the main relationship, and having less than a bachelor's degree level of education. But upon controlling for possible overlap among factors, desire for intimacy, low education levels and to a lesser extent older age survived as the strongest predictors of using PrEP.

Relationships matter

An important implication of the study's findings are that as physicians and counselors discuss PrEP with MSM in steady relationships, Gamarel said, they should consider that a desire for intimacy in the relationship appears to be a prime motivation.

"For people who are disseminating PrEP or talking to patients about PrEP, I think it's important to think about their relationships," Gamarel said. "Something that's being supported and endorsed right now by the World Health Organization is couples voluntary testing and counseling. That may be a way to disseminate PrEP and to allow couples to have a discussion about whether PrEP is good for their and how they can support each other using PrEP."

Gamarel cautioned that the study results cannot be taken as evidence that PrEP will reduce condom use. The men in this study were already forgoing condoms at times without being on PrEP, Gamarel notes. The study simply sought to ascertain whether these men would adopt PrEP and to determine why. Condoms remain uniquely important to gay 's sexual health, she noted, both because they reduce the risk of HIV transmission and because they can block other that PrEP does not.

Explore further: Do men who have sex with men underestimate their HIV risk and miss out on preventive PrEP?

Related Stories

Do men who have sex with men underestimate their HIV risk and miss out on preventive PrEP?

June 23, 2014
Men who have sex with men (MSM) have a disproportionately high risk of acquiring HIV, and unprotected sex between men accounts for most new HIV diagnoses in the U.S. Yet this population tends to underestimate their HIV risk ...

CDC urges anti-HIV pill for people at high risk of infection

May 15, 2014
(HealthDay)—People deemed to be at high risk for contracting HIV, the virus that causes AIDS, should take anti-HIV medicines that seem to cut transmission risk, the U.S. Centers for Disease Control and Prevention announced ...

Effectiveness of HIV pre-exposure prophylaxis in Peru

October 9, 2012
In this week's PLOS Medicine, Anna Borquez from Imperial College London and an international group of authors developed a mathematical model representing the HIV epidemic among men who have sex with men (MSM) and transwomen ...

Protection against HSV-2 is added benefit of tenofovir

July 2, 2014
(HealthDay)—Tenofovir for HIV-1 preexposure prophylaxis (PrEP) provides the added benefit of protection against herpes simplex virus type 2 (HSV-2) acquisition, according to a study published in the July 1 issue of the ...

US backs expanded AIDS therapy for prevention

May 16, 2014
US health authorities are recommending the daily use of anti-retroviral medication to prevent HIV infection for high-risk groups.

HIV answers raise new ethical questions

July 31, 2013
The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical ...

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.